Angiotensin II type 1 receptor blocker reduces monocyte adhesion to endothelial cells in spontaneously hypertensive rats

Endocrine Journal

Volumn 54, Issue 4, 2007, Pages 605-612

  Ikeda, Fuki ^a   Azuma, Kosuke ^a   Ogihara, Takeshi ^a   Toyofuku, Yukiko ^a   Otsuka, Aiko ^a   Mita, Tomoya ^a   Hirose, Takahisa ^a   Tanaka, Yasushi ^a   Kawamori, Ryuzo ^a   Watada, Hirotaka ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; Hypertension; Monocyte endothelial interaction; NEMOes

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; HYDRALAZINE; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CELL ADHESION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TREATMENT RESPONSE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; ATHEROSCLEROSIS; BLOOD PRESSURE; CELL ADHESION; DEOXYGUANOSINE; ENDOTHELIAL CELLS; HYDRALAZINE; HYPERTENSION; MALE; MONOCYTES; RATS; RATS, INBRED SHR; TETRAZOLES; TUNICA INTIMA; TUNICA MEDIA; VALINE;

EID: 34548668447     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07-004     Document Type: Article

References (25)

1. Dzau VJ (2001) Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37: 1047-1052.
2. Chae CU, Lee RT, Rifai N, Ridker PM (2001) Blood pressure and inflammation in apparently healthy men. Hypertension 38: 399-403.
3. Ghiadoni L, Virdis A, Magagna A, Taddei S, Salvetti A (2000) Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Hypertension 35: 501-506.
4. Rizzoni D, Porteri E, Piccoli A, Castellano M, Bettoni G, Muiesan ML, Pasini G, Guelfi D, Mulvany MJ, Agabiti Rosei E (1998) Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension 32: 305-310.
5. Alderman MH (1995) Plasma renin activity and coronary heart disease: are they related? Curr Opin Nephrol Hypertens 4: 201-203.
6. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359: 1004-1010.
7. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A (2004) Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 363: 2022-2031.
8. Strauss MH, Hall AS (2006) Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox. Circulation 114: 838-854.
9. Tsuyuki RT, McDonald MA (2006) Angiotensin receptor blockers do not increase risk of myocardial infarction. Circulation 114: 855-860.
10. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126.
11. Alvarez A, Cerda-Nicolas M, Naim Abu Nabah Y, Mata M, Issekutz AC, Panes J, Lobb RR, Sanz MJ (2004) Direct evidence of leukocyte adhesion in arterioles by angiotensin II. Blood 104: 402-408.
12. Ferrario CM, Strawn WB (2006) Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98: 121-128.
13. Brasier AR, Recinos A 3rd, Eledrisi MS (2002) Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 22: 1257-1266.
14. Hernandez-Presa M, Bustos C, Ortego M, Tunon J, Renedo G, Ruiz-Ortega M, Egido J (1997) Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemo-attractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95: 1532-1541.
15. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM (1998) Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83: 952-959.
16. Mateo T, Abu Nabah YN, Abu Taha M, Mata M, Cerda-Nicolas M, Proudfoot AE, Stahl RA, Issekutz AC, Cortijo J, Morcillo EJ, Jose PJ, Sanz MJ (2006) Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines. J Immunol 176: 5577-5586.
17. Azuma K, Watada H, Niihashi M, Otsuka A, Sato F, Kawasumi M, Shimada S, Tanaka Y, Kawamori R, Mitsumata M (2003) A new En face method is useful to quantitate endothelial damage in vivo. Biochem Biophys Res Commun 309: 384-390.
18. Azuma K, Kawamori R, Toyofuku Y, Kitahara Y, Sato F, Shimizu T, Miura K, Mine T, Tanaka Y, Mitsumata M, Watada H (2006) Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 26: 2275-2280.
19. Azuma K, Toyofuku Y, Iesaki T, Otsuka A, Tanaka A, Mita T, Hirose T, Tanaka Y, Daida H, Kawamori R, Watada H (2006) Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 345: 688-693.
20. Tanaka A, Azuma K, Toyofuku Y, Kurokawa A, Otsuka A, Mita T, Hirosea T, Fujitani Y, Miyauchi K, Daida H, Kawamori R, Watada H (2006) Insulin and nateglinide reduce monocyte adhesion to endothelial cells in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 350: 195-201.
21. Otsuka A, Azuma K, Iesaki T, Sato F, Hirose T, Shimizu T, Tanaka Y, Daida H, Kawamori R, Watada H (2005) Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta. Diabetologia 48: 2667-2674.
22. Okamoto K, Aoki K (1963) Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27: 282-293.
23. Horie R, Kihara M, Lovenberg W, Ben-Ishay D, Bianchi G, Iwai J, Nagaoka A, Rapp JP, Sassard J, Simpson FO, et al. (1986) Comparison of various genetic hypertensive rat strains. J Hypertens (Suppl 4): S11-14.
24. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI (2001) Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 19: 857-861.
25. Blake GJ, Ridker PM (2001) Novel clinical markers of vascular wall inflammation. Circ Res 89: 763-771.